Elizabeth Garner is a seasoned pharmaceutical executive with a career-long focus on addressing unsolved issues and conditions that affect women’s health and quality of life. Dr. Garner is currently Chief Scientific Officer of Ferring Pharmaceuticals US and has held previous positions as Chief Medical Officer of ObsEva and Agile Therapeutics, and senior positions at Myriad Genetics, Abbott Laboratories, and Merck Research Labs. Beth is on the Boards of Directors of Kezar Life Sciences and Sermonix Pharmaceuticals and is the Chair of the Board of NUA Surgical. She is also the Immediate Past President of the American Medical Women’s Association (AMWA), a professional organization whose mission is to advance women in medicine, advocate for equity, and ensure excellence in healthcare. Dr. Garner received her M.D. and M.P.H. degrees from Harvard Medical School and the Harvard School of Public Health and trained in Obstetrics and Gynecology and Gynecologic Oncology at Brigham and Women’s and Massachusetts General Hospitals and the Dana Farber Cancer Institute. Beth is a frequent speaker on a range of topics including the health of women, women’s leadership, and clinical trial diversity; she is a 2019 and 2023 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry and was the 2022 recipient of the Woman in Science Award from AMWA.

Christoph works since more than 30 years as a statistician in the pharmaceutical industry. He is Bayer’s expert statistician for Womens’ Healthcare and for Health Technology Assessment. Christoph is an EFSPI council member and since over 10 years the regulatory chair of EFSPI. He is also member of several scientific advisory groups for EMA and the European Commission. In his spare time Christoph teaches experimental gynaecology at the Saarland State University and leads the local chapter of the pan-European party Volt.

Christoph’s involvement in women’s health started when he joined Schering AG in 1996. His Ph.D. thesis was entitled “Development of two methodological guidelines for the evaluation of bleeding patterns – A tool for registration and prescription on the basis of an empirical analysis”. Christoph (co-)authored many papers on methodological topics in women’s health and he is also a co-developer of several PRO instruments in the field of women’s health.

Dr. Radu Cimpeanu is Associate Professor (Reader) in Applied Mathematics at the University of Warwick, specialising in the mathematical modelling of real-world systems. His primary research interests lie at the interface between fluid mechanics, scientific computing and numerical solutions for partial differential equations, with a particular interest in knowledge transfer and industrial mathematics (and a keen supporter of the Study Groups with Industry format). Radu has so far developed methodologies used to address technologically relevant problems in areas such as microfluidics, aircraft surface de-icing and spray atomisation. He is currently Deputy Director of the Warwick Fluid Dynamics Research Centre, and Executive Committee member of the UK Fluids Network, while also supporting the UKRI National Fellowships in Fluid Dynamics (NFFDy) programme.

Jack Wilkinson is a Senior Lecturer in the Centre for Biostatistics, University of Manchester. His research interests cover both the application, development, and criticism of methods for the evaluation of health interventions, with a particular interest in interventions for the treatment of subfertility, including assisted reproductive technologies (ART). He holds Statistics or Methodological Editor roles for Cochrane Gynaecology and Fertility, BJOG: An International Journal of Obstetrics and Gynaecology, Fertility and Sterility and Reproduction and Fertility. He is currently leading the NIHR-funded INSPECT-SR project, which aims to develop a tool for identifying ‘problematic’ randomised controlled trials, including those subject to data fabrication or falsification.